SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharmaceutical Industries informs about scheme of arrangement

03 Dec 2018 Evaluate

Sun Pharmaceutical Industries has informed that Scheme of Arrangement among Sun Pharma Global FZE and the company and their respective members and creditors for demerger of the Specified Undertaking (as defined in the Scheme of Arrangement) of Sun Pharma Global FZE into the company, is effective from December 01, 2018 as the company has filed the National Company Law Tribunal order along with Scheme of Arrangement in E-form INC-28 with Registrar of Companies, Gujarat on December 01, 2018. The appointed date for the said Scheme of Arrangement is April 01, 2017.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Inds. Share Price

1654.70 -62.65 (-3.65%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×